Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
about
Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.From inception to output, Tcf1 and Lef1 safeguard development of T cells and innate immune cells.Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose.
P2860
Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of DNA-dependen ...... lymphocyte enhancer factor 1.
@en
Identification of DNA-dependen ...... lymphocyte enhancer factor 1.
@nl
type
label
Identification of DNA-dependen ...... lymphocyte enhancer factor 1.
@en
Identification of DNA-dependen ...... lymphocyte enhancer factor 1.
@nl
prefLabel
Identification of DNA-dependen ...... lymphocyte enhancer factor 1.
@en
Identification of DNA-dependen ...... lymphocyte enhancer factor 1.
@nl
P2093
P2860
P1476
Identification of DNA-dependen ...... lymphocyte enhancer factor 1.
@en
P2093
Akihiko Takasaki
Atsushi Shimomura
Nobuhiro Hayashi
Ryuji Nomura
Takao Senda
P2860
P2888
P356
10.1007/S00795-012-0002-Z
P577
2013-01-17T00:00:00Z